Testing effectiveness (Phase 2)Study completedNCT01620255What this trial is testingPF-00547659 In Patients With Moderate To Severe Ulcerative ColitisWho this might be right forUlcerative Colitis Shire 357
Testing effectiveness (Phase 2)Active Not RecruitingNCT07232576What this trial is testingEvaluate the Efficacy, Safety and Pharmacokinetics of SHR-1139 in Patients With Moderate-to-severe Active Ulcerative ColitisWho this might be right forAdult Patients With Moderately to Severely Active Ulcerative Colitis Guangdong Hengrui Pharmaceutical Co., Ltd 21
Large-scale testing (Phase 3)Study completedNCT04779307What this trial is testingVedolizumab in Children and Teenagers With Moderate to Severe Ulcerative Colitis (UC)Who this might be right forColitis, Ulcerative Takeda 121
Testing effectiveness (Phase 2)Study completedNCT04004611What this trial is testingMirikizumab (LY3074828) in Children and Teenagers With Ulcerative Colitis (UC)Who this might be right forUlcerative Colitis Eli Lilly and Company 26
Post-approval studies (Phase 4)Study completedNCT02155335What this trial is testingPreference for a Prefilled Syringe or Smartject™ Device for Delivering Golimumab in Participants Suffering From Moderate-to-severe Ulcerative Colitis (MK-8259-027)Who this might be right forUlcerative Colitis Merck Sharp & Dohme LLC 100
Large-scale testing (Phase 3)Study completedNCT02914522What this trial is testingStudy to Evaluate the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative ColitisWho this might be right forUlcerative Colitis Gilead Sciences 1,351
Testing effectiveness (Phase 2)Study completedNCT00787202What this trial is testingInvestigate The Safety And Efficacy Of CP- 690,550 In Patients With Moderate And Severe Ulcerative Colitis.Who this might be right forUlcerative Colitis Pfizer 195
Not applicableStudy completedNCT03532932What this trial is testingEvaluate Disease Control and Treatment Pattern in Participants With Moderate to Severe Inflammatory Bowel Disease (IBD) in Real Life PracticeWho this might be right forColitis, UlcerativeCrohn DiseaseInflammatory Bowel Diseases Takeda 1,990
Testing effectiveness (Phase 2)Looking for participantsNCT07483073What this trial is testingA Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's DiseaseWho this might be right forColitis, UlcerativeCrohn Disease Eli Lilly and Company 60
Testing effectiveness (Phase 2)Looking for participantsNCT03167437What this trial is testingAn Open-Label, Proof of Consent Study of Vorinostat for the Treatment of Mdoerate-to-Severe Crohn s Disease and Maintenance Therapy With UstekinumabWho this might be right forCrohn's Disease National Institute of Allergy and Infectious Diseases (NIAID) 35
Testing effectiveness (Phase 2)Study completedNCT03368118What this trial is testingStudy Evaluating the Long-term Safety and Efficacy of ABX464 in Active Ulcerative ColitisWho this might be right forUlcerative Colitis Abivax S.A. 22
Testing effectiveness (Phase 2)Study completedNCT04700449What this trial is testingA Study Assessing the Efficacy and Safety of CBP-307 in Subjects With Moderate to Severe Ulcerative Colitis (UC)Who this might be right forModerate to Severe Ulcerative Colitis Connect Biopharm LLC 145
Large-scale testing (Phase 3)Active Not RecruitingNCT06260163What this trial is testingGuselkumab in Pediatric Participants With Moderately to Severely Active Ulcerative ColitisWho this might be right forColitis, Ulcerative Janssen Research & Development, LLC 112
Post-approval studies (Phase 4)Study completedNCT03029143What this trial is testingVedolizumab Intravenous (IV) Dose Optimization in Ulcerative ColitisWho this might be right forColitis, Ulcerative Takeda 278
Post-approval studies (Phase 4)Looking for participantsNCT06581328What this trial is testingVedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community SettingWho this might be right forUlcerative ColitisCrohn's Disease Takeda 200
Testing effectiveness (Phase 2)Study completedNCT04882007What this trial is testingStudy of OSE-127 vs Placebo in Patients With Moderate to Severe Active Ulcerative ColitisWho this might be right forUlcerative Colitis OSE Immunotherapeutics 136
Large-scale testing (Phase 3)Study completedNCT02065622What this trial is testingStudy to Evaluate the Safety and Efficacy of Two Adalimumab Dosing Regimens in Subjects With Moderate to Severe Ulcerative ColitisWho this might be right forUlcerative Colitis (UC) AbbVie 952
Large-scale testing (Phase 3)Study completedNCT00385736What this trial is testingEfficacy and Safety of Adalimumab in Subjects With Moderately to Severely Acute Ulcerative ColitisWho this might be right forUlcerative Colitis Abbott 576
Not applicableStudy completedNCT07695636What this trial is testingEffectiveness and Safety of Mirikizumab in Patients With Moderate-to-severe Ulcerative Colitis: a Real-life Retrospective Multicenter StudyWho this might be right forUlcerative Colitis (UC) IRCCS San Raffaele 282
Early research (Phase 1)Ended earlyNCT01851343What this trial is testingBone Marrow Stromal Cells for Inflammatory Bowel DiseasesWho this might be right forInflammatory Bowel Disease National Institute of Allergy and Infectious Diseases (NIAID) 8